Defibrillators news | Breaking defibrillators news | Defibrillators

FDA lifts penalties on Boston Scientific

...The resolution of these deficiencies will enable the company to win approvals for its new heart-rhythm products in the US, Several thousands of Boston Scientific’s Bloomberg quoted Daniel Owczarski, an analyst at Soleil-Belmont Harbor Research, as saying, "Boston Scientific can operate at full capacity, and all the development programs can go full-steam ahead." Recommend this article to a friend Boston Scientific Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using Standard&Poor's ComStock Inc.

and others.

Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.

All content copyright newratings.com.

All rights reserved.

Republication or redistribution strictly prohibited without the prior written consent of newratings.com.

In no event shall newratings.com be held liable for this or any other content, or for any actions taken in reliance thereon....

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news